跳至主要内容
临床试验/NCT00178230
NCT00178230已完成不适用

Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity in Thoracic Malignancies

University of Rochester1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 1996年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
82
试验地点
1

研究概览

简要总结

This study is being conducted by the University of Rochester Cancer Center to determine the levels of cytokines in the blood, and to determine if blood levels of these cytokines are related to the side effects of radiation therapy combined with other treatments.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients receiving radiation therapy for lung cancer combined with surgery either pre or post RT to the chest for lung cancer not associated with atelectasis, pleural effusion.
  • Patients receiving HDR Brachytherapy for lung cancer.
  • Patients receiving concomitant radiation and interferon therapy for lung cancer.
  • Patients receiving concomitant chemotherapy and radiation for lung cancer. Prior drug therapy does not make patients ineligible.
  • Karnofsky ≥ 70 %.
  • There are no age restrictions.
  • Acceptable bone marrow function - WBC 2 3000/mm3, platelet count > 100,000, hematocrit ≥ 33%, hemoglobin ≥ 11 gms/dl.
  • Life expectancy > 6 months.
  • Patients must sign informed consent meeting all federal and institutional guidelines.

排除标准

  • Patients not meeting eligibility criteria stated above

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuhchyau Chen

Proffessor

University of Rochester

研究点 (1)

Loading locations...

相似试验

Circulating Cytokines as Predictors of Radiation... | 临床试验